Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18441 | 487 | 48.2 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1297 | 8148 | BRAIN BEHAVIOR AND IMMUNITY//PSYCHONEUROIMMUNOLOGY//EXERCISE IMMUNOLOGY REVIEW |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEONEUROGENESIS | Author keyword | 12 | 86% | 1% | 6 |
2 | METASTASIS FORMATION | Author keyword | 4 | 42% | 2% | 8 |
3 | BP6 TU2 FIBROSARCOMA CELLS | Author keyword | 2 | 67% | 0% | 2 |
4 | CANC ANAESTHESIA PAIN MED | Address | 2 | 67% | 0% | 2 |
5 | CARCINOGENESIS DEV THER EUT PROGRAM | Address | 2 | 67% | 0% | 2 |
6 | COUSINS PNI | Address | 2 | 67% | 0% | 2 |
7 | GERONTOL P MED | Address | 2 | 67% | 0% | 2 |
8 | MOL CANC ANAL | Address | 2 | 67% | 0% | 2 |
9 | NEUROBIOLOGY OF CANCER | Author keyword | 2 | 67% | 0% | 2 |
10 | SERV CARDIOL MED INTERNE | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEONEUROGENESIS | 12 | 86% | 1% | 6 | Search NEONEUROGENESIS | Search NEONEUROGENESIS |
2 | METASTASIS FORMATION | 4 | 42% | 2% | 8 | Search METASTASIS+FORMATION | Search METASTASIS+FORMATION |
3 | BP6 TU2 FIBROSARCOMA CELLS | 2 | 67% | 0% | 2 | Search BP6+TU2+FIBROSARCOMA+CELLS | Search BP6+TU2+FIBROSARCOMA+CELLS |
4 | NEUROBIOLOGY OF CANCER | 2 | 67% | 0% | 2 | Search NEUROBIOLOGY+OF+CANCER | Search NEUROBIOLOGY+OF+CANCER |
5 | SMALL AIRWAY EPITHELIAL CELL | 1 | 100% | 0% | 2 | Search SMALL+AIRWAY+EPITHELIAL+CELL | Search SMALL+AIRWAY+EPITHELIAL+CELL |
6 | STRESS NEUROTRANSMITTERS | 1 | 100% | 0% | 2 | Search STRESS+NEUROTRANSMITTERS | Search STRESS+NEUROTRANSMITTERS |
7 | BETA 2 AR | 1 | 33% | 1% | 3 | Search BETA+2+AR | Search BETA+2+AR |
8 | ADAPTATION TO CANCER | 1 | 50% | 0% | 1 | Search ADAPTATION+TO+CANCER | Search ADAPTATION+TO+CANCER |
9 | ADRBK2 | 1 | 50% | 0% | 1 | Search ADRBK2 | Search ADRBK2 |
10 | ALVEOLAR CARCINOMA | 1 | 50% | 0% | 1 | Search ALVEOLAR+CARCINOMA | Search ALVEOLAR+CARCINOMA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | METASTASIS DEVELOPMENT | 42 | 94% | 3% | 15 |
2 | RESEARCH DATALINK COHORT | 3 | 100% | 1% | 3 |
3 | TOBACCO SPECIFIC CARCINOGEN | 3 | 12% | 4% | 19 |
4 | 26 L5 CARCINOMA CELLS | 2 | 33% | 1% | 6 |
5 | PROMOTES TUMOR GROWTH | 2 | 13% | 3% | 16 |
6 | BETA BLOCKER USAGE | 2 | 67% | 0% | 2 |
7 | METASTATIC GENE EXPRESSION | 2 | 67% | 0% | 2 |
8 | POTASSIUM CHANNELS GIRKS | 2 | 67% | 0% | 2 |
9 | SENSORY NEURONS PROMOTES | 2 | 31% | 1% | 5 |
10 | 4 METHYINITROSAMINO 1 3 PYRIDYL 1 BUTANONE | 1 | 100% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Beta-adrenergic blocking drugs in breast cancer: a perspective review | 2012 | 13 | 52 | 85% |
Catecholamines Regulate Tumor Angiogenesis | 2009 | 56 | 22 | 55% |
beta-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy | 2013 | 9 | 113 | 64% |
Neuroendocrine modulation of cancer progression | 2009 | 41 | 40 | 43% |
b-adrenergic-blocking drugs and melanoma: current state of the art | 2012 | 3 | 29 | 76% |
Are Beta Blockers New Potential Anticancer Agents? | 2014 | 0 | 85 | 75% |
A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response | 2014 | 2 | 101 | 37% |
beta-blockers: a novel class of antitumor agents | 2012 | 7 | 112 | 50% |
Biobehavioral Factors and Cancer Progression: Physiological Pathways and Mechanisms | 2011 | 37 | 99 | 29% |
Intercepting neoplastic progression in lung malignancies via the beta adrenergic (beta-AR) pathway: Implications for anti-cancer drug targets | 2012 | 10 | 67 | 42% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC ANAESTHESIA PAIN MED | 2 | 67% | 0.4% | 2 |
2 | CARCINOGENESIS DEV THER EUT PROGRAM | 2 | 67% | 0.4% | 2 |
3 | COUSINS PNI | 2 | 67% | 0.4% | 2 |
4 | GERONTOL P MED | 2 | 67% | 0.4% | 2 |
5 | MOL CANC ANAL | 2 | 67% | 0.4% | 2 |
6 | SERV CARDIOL MED INTERNE | 2 | 67% | 0.4% | 2 |
7 | MED SURG FETAL NEONATAL | 2 | 50% | 0.6% | 3 |
8 | RUTGERS ENDOCRINE PROGRAM | 2 | 50% | 0.6% | 3 |
9 | SIGNAL TRANSDUCT BIOGEN AMINES | 2 | 28% | 1.0% | 5 |
10 | BIOMED EDUC ZBAF | 2 | 33% | 0.8% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000158407 | SOCIAL HLTH AFFAIRS//BREAST DISEASE//DEPRESSIVE MOOD DISORDERS |
2 | 0.0000140242 | CLPTM1L//CHRNA3//TERT CLPTM1L |
3 | 0.0000114479 | MTUS1//ATIP//INVERSE PROBABILITY OF TREATMENT WEIGHT |
4 | 0.0000093421 | MADB106//OUTCOMES CONSORTIUM//BLOOD LEUKOCYTES |
5 | 0.0000072295 | AZ64//TROPOMYOSIN RECEPTOR KINASES//CEP 701 |
6 | 0.0000067477 | SPIPERONE BINDING//EXPT RHEUMATOL NEUROENDOCRINE IMMUNOL//NEUROENDOCRINOIMMUNOL |
7 | 0.0000063262 | DNA SINGLE STRAND SCISSION//REPLICATIVE DNA SYNTHESIS//N METHYL N NITRO N NITROSOGUANIDINE |
8 | 0.0000060831 | WOUND HEALING TISSUE REGENERAT//MICROBICIDAL POTENTIAL//WOMEN CHILD FAMILY HLTH SCI |
9 | 0.0000057824 | HIGH DOSE METHYLPREDNISOLONE//GRP MOL ONCOSURG//AMINOSTEROID |
10 | 0.0000057608 | ONCOL AH ROFFO//FLUORESCENCE VOLTAGE MEASUREMENT//HIV IGA |